Literature DB >> 28709865

Overexpression of Pofut1 and activated Notch1 may be associated with poor prognosis in breast cancer.

Guoxing Wan1, Lin Tian2, Yuandong Yu1, Fang Li1, Xuanbin Wang3, Chen Li1, Shouheng Deng1, Xiongjie Yu1, Xiaojun Cai1, Zhigang Zuo1, Fengjun Cao4.   

Abstract

PURPOSE: The present study was to evaluate the prognostic value of protein expression of Pofut1 and Notch1 signaling in breast cancer.
MATERIAL AND METHODS: Formalin-fixed paraffin-embedded 314 breast specimens including 174 infiltrating ductal carcinoma(IDC), 50 ductal carcinoma in situ(DCIS) and 90 adjacent normal tissue(ANT) were immunohistochemically examined to evaluate the protein expression of Pofut1, activated Notch1(N1IC) and Slug on specimens. Survival analysis was performed by Kaplan-Meier method and Cox's proportional-hazards model. A online database was computationally used to further explore the prognostic role of Pofut1 and Notch1 mRNA expression by Kaplan-Meier Plotter.
RESULTS: Pofut1, Slug and N1IC expression were significantly increased in IDC compared to ANT(all p < 0.05). High expression of Pofut1, Slug and N1IC were associated with tumor aggressiveness including lymph node metastasis (LNM: p = 0.005 for Pofut1, p < 0.001 for N1IC, p = 0.017 for Slug), advanced stage(p = 0.039 for Pofut1, p = 0.025 for N1IC) and higher histological grade(p = 0.001 for N1IC). Additionally, high expression of Pofut1 was found to be significantly associated with high expressions of N1IC and Slug in IDC(r = 0.244, p = 0.001; r = 0.374, p < 0.001, respectively), similar correlation was also observed between high N1IC and Slug expression(r = 0.496, p < 0.001). Moreover, Kaplan-Meier and Cox's regression analysis indicated the significant prognostic value of elevated Pofut1, N1IC, Slug expressions, positive LNM and advanced tumor stage for the prediction of a shorter disease-free survival (DFS) and overall survival(OS). The web-based analysis also suggested a significant association of high Pofut1 and Notch1 mRNA expression with worse survival outcome.
CONCLUSION: Our findings suggested that overexpression of Pofut1 and activated Notch1 signaling may be associated with a poor prognosis in breast cancer.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Notch1; Pofut1; Prognosis; Slug

Mesh:

Substances:

Year:  2017        PMID: 28709865     DOI: 10.1016/j.bbrc.2017.07.053

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Other Types of Glycosylation.

Authors:  Yohei Tsukamoto; Hideyuki Takeuchi
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

2.  Low expression of cytosolic NOTCH1 predicts poor prognosis of breast cancer patients.

Authors:  Yi-Ling Chen; Kuo-Ting Lee; Chih-Yang Wang; Che-Hung Shen; Sheau-Chiann Chen; Wei-Pang Chung; Ya-Ting Hsu; Yao-Lung Kuo; Pai-Sheng Chen; Chun Hei Antonio Cheung; Chih-Peng Chang; Meng-Ru Shen; Hui-Ping Hsu
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

3.  Fucosylation genes as circulating biomarkers for lung cancer.

Authors:  Qixin Leng; Jen-Hui Tsou; Min Zhan; Feng Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2018-08-12       Impact factor: 4.553

Review 4.  Multifaceted regulation of Notch signaling by glycosylation.

Authors:  Ashutosh Pandey; Nima Niknejad; Hamed Jafar-Nejad
Journal:  Glycobiology       Date:  2021-01-09       Impact factor: 4.313

5.  POFUT1 acts as a tumor promoter in glioblastoma by enhancing the activation of Notch signaling.

Authors:  Qi Li; Jia Wang; Xudong Ma; Maode Wang; Lei Zhou
Journal:  J Bioenerg Biomembr       Date:  2021-07-12       Impact factor: 2.945

6.  SIRT1 promotes formation of breast cancer through modulating Akt activity.

Authors:  Xiaoxia Jin; Yingze Wei; Feng Xu; Min Zhao; Kui Dai; Rong Shen; Shuyun Yang; Nong Zhang
Journal:  J Cancer       Date:  2018-04-30       Impact factor: 4.207

7.  Positive Caricature Transcriptomic Effects Associated with Broad Genomic Aberrations in Colorectal Cancer.

Authors:  Daniele F Condorelli; Giorgia Spampinato; Giovanna Valenti; Nicolò Musso; Sergio Castorina; Vincenza Barresi
Journal:  Sci Rep       Date:  2018-10-04       Impact factor: 4.379

8.  POFUT1 promotes colorectal cancer development through the activation of Notch1 signaling.

Authors:  Yuheng Du; Daojiang Li; Nanpeng Li; Chen Su; Chunxing Yang; Changwei Lin; Miao Chen; Runliu Wu; Xiaorong Li; Gui Hu
Journal:  Cell Death Dis       Date:  2018-09-24       Impact factor: 8.469

9.  POFUT1 as a Promising Novel Biomarker of Colorectal Cancer.

Authors:  Julien Chabanais; François Labrousse; Alain Chaunavel; Agnès Germot; Abderrahman Maftah
Journal:  Cancers (Basel)       Date:  2018-10-30       Impact factor: 6.639

10.  Downregulation of POFUT1 Impairs Secondary Myogenic Fusion Through a Reduced NFATc2/IL-4 Signaling Pathway.

Authors:  Audrey Der Vartanian; Julien Chabanais; Claire Carrion; Abderrahman Maftah; Agnès Germot
Journal:  Int J Mol Sci       Date:  2019-09-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.